Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00099554
NCT00099554
View on ClinicalTrials.gov
Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)
PHASE4
Completed
INTERVENTIONAL
Enrollment
200
Participants
Timeline
Start Date
May 31, 2004
Conditions
Rheumatoid Arthritis
Interventions
DRUG
Etanercept
Sponsors
Lead Sponsor
Amgen
All Listed Sponsors
lead
Amgen
INDUSTRY
NCT00099554 - Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab) | Biotech Hunter | Biotech Hunter